John E. Harris, MD, PhD, reviews factors that shape prevalence of vitiligo and also explores the impact of vitiligo on patient quality of life.
Back
Vitiligo: Practical Considerations for a Changing Therapeutic Landscape
Experts share insights on evolving knowledge and treatment approaches regarding vitiligo, in highlights from a recent State of the Science SummitTM, presented by HCP Live®.
Vitiligo: Practical Considerations for a Changing Therapeutic Landscape
Episodes
All
All
Pearl E. Grimes, MD, discusses intervention strategies for vitiligo, including stabilization, repigmentation, and maintenance. She also explores factors that impact therapeutic outcomes.
Seemal R. Desai, MD, examines the mechanisms of JAK inhibitors and why these agents play an important role in the treatment of vitiligo.
Iltefat Hamzavi, MD, explores key areas of patient communication that may shape adherence and outcomes in patients with vitiligo.
Advertisement
Advertisement